Clinical Data on Medtronic, Inc.’s Cardiovascular Innovations to Feature Prominently at U.S. Cardiology Meeting

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT), today announced highlights of clinical data presentations scheduled for the 2009 American College of Cardiology (ACC) meeting that feature the company’s cardiovascular innovations, including the Endeavor Drug-Eluting Stent (DES) and the Export Aspiration Catheter. ACC.09 takes place in Orlando March 28–31 at the Orange County Convention Center.
MORE ON THIS TOPIC